L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 31,550
+50 (0.16%)
Aug 14, 2025, 2:40 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 773.03 billion as of August 14, 2025. Its market cap has increased by 58.13% in one year.
Market Cap
773.03B
Enterprise Value
888.53B
Revenue
73.32B
Ranking
n/a
PE Ratio
5.57
Stock Price
31,550.00
Market Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 773.03B, an increase of 296.50%. That is a compound annual growth rate of 22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 773.03B | 41.40% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | 754.76B | 300.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.67T |
| Celltrion | 38.80T |
| ALTEOGEN | 24.00T |
| Yuhan | 8,309.02B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,846.99B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,648.08B |